Company Incannex Healthcare Australian S.E.
Equities
IHL
AU000000IHL8
Pharmaceuticals
Business Summary
Number of employees: 3
Managers
Managers | Title | Age | Since |
---|---|---|---|
Joel Latham
CEO | Chief Executive Officer | 35 | 23-07-04 |
Joseph Swan
DFI | Director of Finance/CFO | 33 | 23-07-04 |
Parisa Asvadi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Rosemarie Walsh
CTO | Chief Tech/Sci/R&D Officer | - | 20-04-30 |
Mark Bleackley
CTO | Chief Tech/Sci/R&D Officer | - | - |
Lekhram Changoer
CTO | Chief Tech/Sci/R&D Officer | 58 | 23-07-04 |
Brad Dilkes
IRC | Investor Relations Contact | - | - |
Kalani Scarrott
AUD | Comptroller/Controller/Auditor | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Clark
BRD | Director/Board Member | 64 | Oct. 31 |
Director/Board Member | 60 | Oct. 31 | |
Troy Valentine
CHM | Chairman | 50 | Oct. 31 |
Peter Widdows
BRD | Director/Board Member | 58 | Oct. 31 |
Joel Latham
CEO | Chief Executive Officer | 35 | 23-07-04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 15,873,113 | 12,038,568 ( 75.84 %) | 0 | 75.84 % |
Company contact information
Incannex Healthcare, Inc.
8 Century Circuit Suite 105
2153, Norwest
+61 4 2570 3805
http://www.incannex.com![address Incannex Healthcare(IHL)](https://cdn.zonebourse.com/static/address/31753213.png)
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+13.97% | 4.99B | |
-32.08% | 3.61B | |
-1.63% | 3.1B | |
-24.62% | 2.64B | |
-9.82% | 2.32B | |
+38.87% | 1.85B | |
+38.84% | 1.43B | |
-15.47% | 1.39B | |
+40.95% | 1.37B |